BVF as of March 31, 2012
Portfolio Holdings for BVF
BVF holds 18 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nektar Therapeutics | 22.7 | $61M | 7.6M | 7.92 | |
| Rigel Pharmaceuticals | 21.1 | $56M | 7.0M | 8.05 | |
| Ligand Pharmaceuticals In (LGND) | 20.8 | $55M | 3.5M | 15.95 | |
| Array BioPharma | 10.5 | $28M | 8.2M | 3.41 | |
| Chemocentryx | 6.0 | $16M | 1.5M | 10.66 | |
| Ironwood Pharmaceuticals (IRWD) | 5.9 | $16M | 1.2M | 13.31 | |
| Oncothyreon | 3.8 | $10M | 2.3M | 4.36 | |
| A.P. Pharma (APPA) | 1.9 | $4.9M | 13M | 0.37 | |
| Myrexis (MYRX) | 1.8 | $4.8M | 1.6M | 3.03 | |
| Palatin Technologies | 1.4 | $3.8M | 5.2M | 0.73 | |
| Flamel Technologies | 1.2 | $3.3M | 643k | 5.13 | |
| Genvec | 1.2 | $3.1M | 1.2M | 2.63 | |
| Targacept | 0.6 | $1.5M | 296k | 5.12 | |
| Capstone Therapeutics | 0.6 | $1.5M | 7.8M | 0.19 | |
| Pain Therapeutics | 0.2 | $623k | 172k | 3.62 | |
| NeurogesX | 0.2 | $610k | 1.2M | 0.51 | |
| Cadus Corporation | 0.1 | $369k | 269k | 1.37 | |
| AutoImmune (AIMM) | 0.0 | $0 | 3.6M | 0.00 |
